drugset
drugset / Trial / NCT03997812

Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy

NCT03997812 ↗

Phase 2 Completed 60 enrolled Vivozon, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections for treating post-operative pain following bunionectomy.

Timeline

Start
2019-05-23
Primary completion
2019-08-07
Completion
2019-08-21

Drugs

EvaluationDrugModalityDoseRoute
Subject VVZ-149 Small molecule 1000 mg Intravenous

Indications

neuropathy, painful